Litcius/Paper detail

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer, Marco Campisi, Tatsuya Osaki, Koji Haratani, Minyue Chen, Erik H. Knelson, Navin R. Mahadevan, Jessica Ritter, Ryohei Yoshida, Jens Köhler, Atsuko Ogino, Ryu‐Suke Nozawa, Shriram K. Sundararaman, Tran C. Thai, Mizuki Homme, Brandon Piel, Sophie Kivlehan, Bonje Obua, Connor Purcell, Mamiko Yajima, Thanh U. Barbie, Patrick H. Lizotte, Pasi A. Jänne, Cloud P. Paweletz, Prafulla C. Gokhale, David A. Barbie

2022Cancer Cell101 citationsDOIOpen Access PDF

Topics & Concepts

Cancer researchIntracellularApoptosisProgrammed cell deathBiologyIn vivoCell biologyStingBiochemistryBiotechnologyAerospace engineeringEngineeringinterferon and immune responsesRNA modifications and cancerUbiquitin and proteasome pathways
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer | Litcius